Patient Multichannel Engagement Research

August 27, 2016

Disease-level research to help you plan multichannel patient experiences that drive results

DRG Digital’s disease-specific research and experts help pharma brands:

  • Be in the right channel, with the right content and message to educate patients and support treatment decisions
  • Plan patient-first digital and website experiences
  • Develop digital strategies that increase the effectiveness of offline media campaigns (e.g., TV ads, print)
  • Identify the best opportunities for beyond the pill and value-added resources that support positive outcomes

 

Coverage for  50+ disease states

Insights founded on Cybercitizen Health® and ePharma Consumer® studies from Manhattan Research, a DRG Digital brand.


 

Our intelligence and analysts help you make better informed decisions for reaching and engaging patient audiences, covering areas such as:

 

Multichannel engagement

  • Channel planning
  • Customer experience
  • Websites & content
  • Video
  • Mobile
  • Social and influencers
  • Email
  • Search
  • TV advertising → digital
  • Adherence tools
  • Patient support programs
  • Much more

 

 

Emerging trends

  • Challenges in the new healthcare ecosystem
  • The digital patient journey
  • Point of care dynamics
  • Beyond the pill technologies
  • Remote care and telehealth
  • Sensors and health tracking
  • New expectations from pharma
  • Much more

Disease states (US):

Patient, Caregiver & Rx taker segments

  • Acid Reflux
  • Acne
  • ADD/ADHD
  • Age-related Macular Degeneration
  • Allergies
  • Angina
  • Arthritis
  • Osteoarthritis
  • Rheumatoid arthritis (mild, moderate-severe)
  • Psoriatic arthritis
  • Parent to child with ankylosing spondylitis
  • Parent to child with juvenile idiopathic arthritis
  • Parent to child with plaque psoriasis
  • Parent to child with Crohn's Disease
  • Arrhythmia
  • Asthma (mild, moderate-severe)
  • Atrial Fibrillation
  • Autism
  • Atopic dermatitis
  • Bipolar Disorder
  • Cancer (diagnosed past 3 years)
  • Breast Cancer
  • Prostate Cancer
  • Skin Cancer
  • Chronic Pain
  • Chronic Bronchitis
  • Chronic kidney disease
  • COPD
 

 

  • Crohn's Disease
  • Cystic Fibrosis
  • Deep Vein Thrombosis
  • Depression
  • Diabetes (T1 & T2)
  • Eczema (mild, moderate-severe)
  • Emphysema
  • Epilepsy
  • Erectile Dysfunction
  • Fibromyalgia
  • Generalized Anxiety Disorder
  • Glaucoma
  • Gout 
  • Growth Hormone Deficiency
  • Heart Attack past 3 years (ages 45+)
  • Heart failure
  • Heart Disease
  • Hepatitis C
  • High Cholesterol
  • HIV or AIDS
  • Insomnia or Sleep Disorder
  • Irritable Bowel Syndrome
  • Low testosterone
  • Migraine
  • Multiple Sclerosis
  • Osteoporosis
  • Organ transplant recipient
  • Overactive Bladder or Urinary Incontinence
  • Overweight or obese (Weight management or obesity for info seekers)
  • Psoriasis (mild, moderate-severe)
  • Stroke

 

Previous Article
For the healthcare consumer in 2016, the point of care is digital
For the healthcare consumer in 2016, the point of care is digital

We’ve just wrapped up our CyberCitizen Health® U.S. 2016 study, and in going through the findings, we were ...

Next Article
We asked patients about their digital experience with 30 pharma brands…
We asked patients about their digital experience with 30 pharma brands…